Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 3/2003

01-03-2003 | Original Article

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

Authors: Saroj Basak, Brigitte Birebent, Enkhtsetseg Purev, Rajasekharan Somasundaram, Haruhiko Maruyama, Jan Zaloudik, Rolf Swoboda, Wolfgang Strittmatter, Weiping Li, Albrecht Luckenbach, Hong Song, Jian Li, Katrin Sproesser, Dupont Guerry, Sridar Nair, Koichi Furukawa, Dorothee Herlyn

Published in: Cancer Immunology, Immunotherapy | Issue 3/2003

Login to get access
Metadata
Title
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside
Authors
Saroj Basak
Brigitte Birebent
Enkhtsetseg Purev
Rajasekharan Somasundaram
Haruhiko Maruyama
Jan Zaloudik
Rolf Swoboda
Wolfgang Strittmatter
Weiping Li
Albrecht Luckenbach
Hong Song
Jian Li
Katrin Sproesser
Dupont Guerry
Sridar Nair
Koichi Furukawa
Dorothee Herlyn
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2003
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-002-0340-0

Other articles of this Issue 3/2003

Cancer Immunology, Immunotherapy 3/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine